Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Safety and efficacy of Rapamune® (Sirolimus) in kidney transplant recipients: results of a prospective post-marketing surveillance study in Korea ; volume:19 ; number:1 ; day:13 ; month:8 ; year:2018 ; pages:1-11 ; date:12.2018
BMC nephrology ; 19, Heft 1 (13.8.2018), 1-11, 12.2018
- Urheber
-
Jeon, Hee Jung
- Beteiligte Personen und Organisationen
-
Lee, Hahn-Ey
Yang, Jaeseok
SpringerLink (Online service)
- DOI
-
10.1186/s12882-018-1002-6
- URN
-
urn:nbn:de:101:1-2018102715443583119494
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jeon, Hee Jung
- Lee, Hahn-Ey
- Yang, Jaeseok
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sirolimus in renal transplant recipients with malignancies in Germany
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Immunomonitoring in Transplant Recipients
Malignant tumors in organ transplant recipients
Costimulation Blockade in Kidney Transplant Recipients
Cardiovascular risk in renal transplant recipients
Hypogammaglobulinemia in pediatric kidney transplant recipients
Lung infections in cardiac transplant recipients
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
Immunosuppression Considerations for Older Kidney Transplant Recipients
Sirolimus in renal transplant recipients with malignancies in Germany
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Immunomonitoring in Transplant Recipients
Malignant tumors in organ transplant recipients
Costimulation Blockade in Kidney Transplant Recipients
Cardiovascular risk in renal transplant recipients
Hypogammaglobulinemia in pediatric kidney transplant recipients
Lung infections in cardiac transplant recipients
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
Immunosuppression Considerations for Older Kidney Transplant Recipients
Sirolimus in renal transplant recipients with malignancies in Germany
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
Immunomonitoring in Transplant Recipients
Malignant tumors in organ transplant recipients
Costimulation Blockade in Kidney Transplant Recipients
Cardiovascular risk in renal transplant recipients
Hypogammaglobulinemia in pediatric kidney transplant recipients
Lung infections in cardiac transplant recipients
Topical Sirolimus 0.2% Gel for the Management of Tuberous Sclerosis Complex-Related Cutaneous Manifestations: An Interim Analysis of Postmarketing Surveillance in Japan
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan